| Listed Drug | Form | Manner of Administration |
| Abatacept | Injection 125 mg in 1 mL single dose autoinjector | Injection |
| | Injection 125 mg in 1 mL single dose pre‑filled syringe | Injection |
| Abemaciclib | Tablet 100 mg | Oral |
| | Tablet 150 mg | Oral |
| | Tablet 50 mg | Oral |
| Abiraterone | Tablet containing abiraterone acetate 250 mg | Oral |
| | Tablet containing abiraterone acetate 500 mg | Oral |
| Acalabrutinib | Capsule 100 mg | Oral |
| Acamprosate | Tablet (enteric coated) containing acamprosate calcium 333 mg | Oral |
| Acarbose | Tablet 100 mg | Oral |
| | Tablet 50 mg | Oral |
| Acetazolamide | Tablet 250 mg | Oral |
| Aciclovir | Eye ointment 30 mg per g, 4.5 g (Acivision) | Application to the eye |
| | Tablet 200 mg | Oral |
| | Tablet 800 mg | Oral |
| Acitretin | Capsule 10 mg | Oral |
| | Capsule 25 mg | Oral |
| Aclidinium | Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses | Inhalation by mouth |
| Aclidinium with formoterol | Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth |
| Adalimumab | Injection 20 mg in 0.4 mL pre‑filled syringe | Injection |
| | Injection 40 mg in 0.8 mL pre‑filled pen | Injection |
| | Injection 40 mg in 0.8 mL pre‑filled pen, 4 | Injection |
| | Injection 40 mg in 0.8 mL pre‑filled pen, 6 | Injection |
| | Injection 40 mg in 0.8 mL pre‑filled syringe | Injection |
| | Injection 40 mg in 0.8 mL pre‑filled syringe, 6 | Injection |
| Adapalene with benzoyl peroxide | Gel 1 mg‑25 mg per g, 30 g | Application |
| Adrenaline (epinephrine) | I.M. injection 150 micrograms in 0.3 mL single dose syringe auto‑injector | Injection |
| | I.M. injection 300 micrograms in 0.3 mL single dose syringe auto‑injector | Injection |
| | Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) | Injection |
| Afatinib | Tablet 20 mg | Oral |
| | Tablet 30 mg | Oral |
| | Tablet 40 mg | Oral |
| | Tablet 50 mg | Oral |
| Aflibercept | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe | Injection |
| | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL) | Injection |
| Albendazole | Tablet 200 mg | Oral |
| | Tablet 400 mg | Oral |
| Alectinib | Capsule 150 mg | Oral |
| Alendronic acid | Tablet 70 mg (as alendronate sodium) | Oral |
| Alendronic acid with colecalciferol | Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | Oral |
| | Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol | Oral |
| Alendronic acid with colecalciferol and calcium | Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate) | Oral |
| Allopurinol | Tablet 100 mg | Oral |
| | Tablet 300 mg | Oral |
| Alogliptin | Tablet 12.5 mg (as benzoate) | Oral |
| | Tablet 25 mg (as benzoate) | Oral |
| | Tablet 6.25 mg (as benzoate) | Oral |
| Alogliptin with metformin | Tablet containing 12.5 mg alogliptin (as benzoate) with 1 g metformin hydrochloride | Oral |
| | Tablet containing 12.5 mg alogliptin (as benzoate) with 500 mg metformin hydrochloride | Oral |
| | Tablet containing 12.5 mg alogliptin (as benzoate) with 850 mg metformin hydrochloride | Oral |
| Alprazolam | Tablet 1 mg | Oral |
| | Tablet 250 micrograms | Oral |
| | Tablet 500 micrograms | Oral |
| Amantadine | Capsule containing amantadine hydrochloride 100 mg | Oral |
| Amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids | Oral powder 400 g (Neocate Syneo) | Oral |
| Amino acid formula with carbohydrate, vitamins, minerals and trace elements without phenylalanine | Sachets containing oral powder 20 g, 30 (PKU Go) | Oral |
| Amino acid formula with carbohydrate without phenylalanine | Tablets containing 0.92 g protein, 462 (PKU Easy Tablet) | Oral |
| Amino acid formula with fat, carbohydrate, vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine and supplemented with docosahexaenoic acid | Oral liquid 500 mL, 20 (PKU Baby) | Oral |
| Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine | Bottles containing oral powder 34 g, 30 (PKU Easy Shake & Go) | Oral |
| Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine | Bottles containing oral powder 34 g, 30 (TYR Easy Shake & Go) | Oral |
| Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine, and supplemented with docosahexanoic acid | Oral liquid 125 mL, 36 (TYR Anamix junior LQ) | Oral |
| Amino acid formula with fat, carbohydrate, vitamins, minerals, and trace elements, without methionine and supplemented with docosahexanoic acid | Oral liquid 125 mL, 36 (HCU Anamix junior LQ) | Oral |
| Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides | Oral powder 400 g (Alfamino Junior) | Oral |
| | Oral powder 400 g (Neocate Junior) | Oral |
| Amino acid formula with fat, carbohydrate without methionine | Tablets containing 0.91 g protein, 462 (HCU Easy Tablet) | Oral |
| Amino acid formula with fat, carbohydrate without phenylalanine | Tablets (modified release), 70.8 g protein per 100 g, 110 g, 4 (PKU Easy Microtabs) | Oral |
| Amino acid formula with fat, carbohydrate without phenylalanine and tyrosine | Tablets containing 0.91 g protein, 462 (TYR Easy Tablet) | Oral |
| Amino acid formula with fat, carbohydrate without valine, leucine and isoleucine | Tablets containing 0.91 g protein, 462 (MSUD Easy Tablet) | Oral |
| Amino acid formula with vitamins and minerals without lysine and low in tryptophan | Oral powder 400 g (GA1 Anamix infant) | Oral |
| | Oral powder 500 g (XLYS, LOW TRY Maxamum) | Oral |
| | Sachets containing oral powder 18 g, 30 (GA1 Anamix Junior) | Oral |
| | Sachets containing oral powder 24 g, 30 (GA gel) | Oral |
| | Sachets containing oral powder 25 g, 30 (GA express 15) | Oral |
| Amino acid formula with vitamins and minerals without methionine | Oral liquid 125 mL, 30 (HCU Lophlex LQ 20) | Oral |
| | Oral liquid 130 mL, 30 (HCU cooler 15) | Oral |
| | Oral liquid 174 mL, 30 (HCU cooler 20) | Oral |
| | Oral liquid 87 mL, 30 (HCU cooler 10) | Oral |
| | Oral powder 400 g (HCU Anamix infant) | Oral |
| | Oral powder 500 g (XMET Maxamum) | Oral |
| | Sachets containing oral powder 24 g, 30 (HCU gel) | Oral |
| | Sachets containing oral powder 25 g, 30 (HCU express 15) | Oral |
| | Sachets containing oral powder 36 g, 30 (HCU Anamix Junior) | Oral |
| Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine | Oral powder 400 g (MMA/PA Anamix infant) | Oral |
| | Oral powder 500 g (XMTVI Maxamum) | Oral |
| | Sachets containing oral powder 18 g, 30 (MMA/PA Anamix Junior) | Oral |
| | Sachets containing oral powder 24 g, 30 (MMA/PA gel) | Oral |
| | Sachets containing oral powder 25 g, 30 (MMA/PA express 15) | Oral |
| Amino acid formula with vitamins and minerals without phenylalanine | Oral gel 85 g, 30 (PKU squeezie) | Oral |
| | Oral liquid 125 mL, 30 (PKU Lophlex LQ 20) | Oral |
| | Oral liquid 125 mL, 36 (PKU Anamix Junior LQ) | Oral |
| | Oral liquid 130 mL, 30 (PKU Air 15) | Oral |
| | Oral liquid 130 mL, 30 (PKU Cooler 15) | Oral |
| | Oral liquid 174 mL, 30 (PKU Air 20) | Oral |
| | Oral liquid 174 mL, 30 (PKU Cooler 20) | Oral |
| | Oral liquid 250 mL (Easiphen) | Oral |
| | Oral liquid 62.5 mL, 60 (PKU Lophlex LQ 10) | Oral |
| | Oral liquid 87 mL, 30 (PKU Cooler 10) | Oral |
| | Oral powder 500 g (XP Maxamum) | Oral |
| | Oral semi‑solid 109 g, 36 (PKU Lophlex Sensation 20) | Oral |
| | Sachets containing oral powder 24 g, 30 (PKU gel) | Oral |
| | Sachets containing oral powder 25 g, 30 (PKU express 15) | Oral |
| | Sachets containing oral powder 28 g, 30 (PKU Lophlex) | Oral |
| | Sachets containing oral powder 34 g, 30 (PKU express 20) | Oral |
| | Sachets containing oral powder 36 g, 30 (PKU Anamix Junior) | Oral |
| Amino acid formula with vitamins and minerals without phenylalanine and tyrosine | Oral liquid 125 mL, 30 (TYR Lophlex LQ 20) | Oral |
| | Oral liquid 130 mL, 30 (TYR cooler 15) | Oral |
| | Oral liquid 174 mL, 30 (TYR cooler 20) | Oral |
| | Oral liquid 87 mL, 30 (TYR cooler 10) | Oral |
| | Oral powder 400 g (TYR Anamix infant) | Oral |
| | Oral powder 500 g (XPhen, Tyr Maxamum) | Oral |
| | Sachets containing oral powder 24 g, 30 (TYR gel) | Oral |
| | Sachets containing oral powder 25 g, 30 (TYR express 15) | Oral |
| | Sachets containing oral powder 34 g, 30 (TYR express 20) | Oral |
| | Sachets containing oral powder 36 g, 30 (TYR Anamix Junior) | Oral |
| Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Oral liquid 125 mL, 30 (MSUD Lophlex LQ 20) | Oral |
| | Oral liquid 130 mL, 30 (MSUD cooler 15) | Oral |
| | Oral liquid 174 mL, 30 (MSUD cooler 20) | Oral |
| | Oral liquid 87 mL, 30 (MSUD cooler 10) | Oral |
| | Oral powder 400 g (MSUD Anamix infant) | Oral |
| | Oral powder 500 g (MSUD AID III) | Oral |
| | Oral powder 500 g (MSUD Maxamum) | Oral |
| | Sachets containing oral powder 24 g, 30 (MSUD gel) | Oral |
| | Sachets containing oral powder 25 g, 30 (MSUD express 15) | Oral |
| | Sachets containing oral powder 34 g, 30 (MSUD express 20) | Oral |
| | Sachets containing oral powder 36 g, 30 (MSUD Anamix Junior) | Oral |
| Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid | Oral liquid 125 mL, 36 (MSUD Anamix Junior LQ) | Oral |
| Amino acid formula with vitamins and minerals, low phenylalanine and supplemented with docosahexaenoic acid and arachidonic acid | Sachets containing oral powder 12.5 g, 30 (PKU Anamix First Spoon) | Oral |
| | Sachets containing oral powder 12.5 g, 30 (PKU Explore 5) | Oral |
| | Sachets containing oral powder 25 g, 30 (PKU Explore 10) | Oral |
| Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine | Oral powder 400 g (PKU Anamix infant) | Oral |
| | Oral powder 400 g (PKU Start) | Oral |
| Amino acid formula without phenylalanine | Tablets 1 g, 75 (Phlexy‑10) | Oral |
| Amino acid formula without valine, leucine and isoleucine | Sachets containing oral powder 6 g, 30 (MSUD amino5) | Oral |
| Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids | Oral powder 400 g (EleCare LCP) | Oral |
| | Oral powder 400 g (Neocate LCP) | Oral |
| Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides | Oral powder 400 g (Alfamino) | Oral |
| | Oral powder 400 g (Neocate Gold) | Oral |
| Amino acids‑synthetic, formula | Oral powder 400 g (EleCare) | Oral |
| | Oral powder 400 g (Neocate Junior Vanilla) | Oral |
| Amiodarone | Tablet containing amiodarone hydrochloride 100 mg | Oral |
| | Tablet containing amiodarone hydrochloride 200 mg | Oral |
| Amisulpride | Oral solution 100 mg per mL, 60 mL | Oral |
| | Tablet 100 mg | Oral |
| | Tablet 200 mg | Oral |
| | Tablet 400 mg | Oral |
| Amitriptyline | Tablet containing amitriptyline hydrochloride 10 mg | Oral |
| | Tablet containing amitriptyline hydrochloride 25 mg | Oral |
| | Tablet containing amitriptyline hydrochloride 50 mg | Oral |
| Amlodipine | Tablet 10 mg (as besilate) | Oral |
| | Tablet 5 mg (as besilate) | Oral |
| Amlodipine with atorvastatin | Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) | Oral |
| | Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) | Oral |
| | Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) | Oral |
| | Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) | Oral |
| | Tablet 5 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) | Oral |
| | Tablet 5 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) | Oral |
| | Tablet 5 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) | Oral |
| | Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) | Oral |
| Amlodipine with valsartan | Tablet 10 mg (as besilate)‑160 mg | Oral |
| | Tablet 10 mg (as besilate)‑320 mg | Oral |
| | Tablet 5 mg (as besilate)‑160 mg | Oral |
| | Tablet 5 mg (as besilate)‑320 mg | Oral |
| | Tablet 5 mg (as besilate)‑80 mg | Oral |
| Amlodipine with valsartan and hydrochlorothiazide | Tablet 10 mg (as besilate)‑160 mg‑12.5 mg | Oral |
| | Tablet 10 mg (as besilate)‑160 mg‑25 mg | Oral |
| | Tablet 10 mg (as besilate)‑320 mg‑25 mg | Oral |
| | Tablet 5 mg (as besilate)‑160 mg‑12.5 mg | Oral |
| | Tablet 5 mg (as besilate)‑160 mg‑25 mg | Oral |
| Amoxicillin | Capsule 250 mg (as trihydrate) | Oral |
| | Capsule 500 mg (as trihydrate) | Oral |
| | Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL | Oral |
| | Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL | Oral |
| | Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL | Oral |
| | Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL | Oral |
| | Tablet 1 g (as trihydrate) | Oral |
| Amoxicillin with clavulanic acid | Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL | Oral |
| | Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL | Oral |
| | Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral |
| | Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral |
| Amphotericin B | Lozenge 10 mg | Oral |
| Ampicillin | Powder for injection 1 g (as sodium) | Injection |
| | Powder for injection 500 mg (as sodium) | Injection |
| Amylopectin, modified long chain | Sachets containing oral powder 60 g, 30 (Glycosade) | Oral |
| Anastrozole | Tablet 1 mg | Oral |
| Apixaban | Tablet 2.5 mg | Oral |
| | Tablet 5 mg | Oral |
| Apomorphine | Injection containing apomorphine hydrochloride hemihydrate 100 mg in 20 mL | Injection |
| | Solution for subcutaneous injection containing apomorphine hydrochloride 30 mg in 3 mL pre-filled pen | Injection |
| Apraclonidine | Eye drops 5 mg (as hydrochloride) per mL, 10 mL | Application to the eye |
| Apremilast | Pack containing 4 tablets 10 mg, 4 tablets 20 mg and 19 tablets 30 mg | Oral |
| | Tablet 30 mg | Oral |
| Aprepitant | Capsule 165 mg | Oral |
| Arachidonic acid and docosahexaenoic acid with carbohydrate | Sachets of oral powder 4 g containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid, 30 (keyomega) | Oral |
| Arginine with carbohydrate | Sachets of oral powder 4 g containing 2 g arginine, 30 (Arginine 2000) | Oral |
| | Sachets of oral powder 4 g containing 500 mg arginine, 30 (Arginine 500) | Oral |
| | Sachets of oral powder 7.6 g containing 5 g arginine, 30 (Arginine 5000) | Oral |
| Aripiprazole | Powder for injection 300 mg (as monohydrate) with diluent | Injection |
| | Powder for injection 400 mg (as monohydrate) with diluent | Injection |
| | Tablet 10 mg | Oral |
| | Tablet 15 mg | Oral |
| | Tablet 20 mg | Oral |
| | Tablet 30 mg | Oral |
| Armodafinil | Tablet 150 mg | Oral |
| | Tablet 250 mg | Oral |
| | Tablet 50 mg | Oral |
| Artemether with lumefantrine | Tablet (dispersible) 20 mg‑120 mg | Oral |
| | Tablet 20 mg‑120 mg | Oral |
| Asenapine | Sublingual wafer 10 mg (as maleate) | Sublingual |
| | Sublingual wafer 5 mg (as maleate) | Sublingual |
| Aspirin | Tablet 100 mg | Oral |
| Atenolol | Oral solution 50 mg in 10 mL, 300 mL | Oral |
| | Tablet 50 mg | Oral |
| Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral |
| | Capsule 100 mg (as hydrochloride) | Oral |
| | Capsule 18 mg (as hydrochloride) | Oral |
| | Capsule 25 mg (as hydrochloride) | Oral |
| | Capsule 40 mg (as hydrochloride) | Oral |
| | Capsule 60 mg (as hydrochloride) | Oral |
| | Capsule 80 mg (as hydrochloride) | Oral |
| Atorvastatin | Tablet 10 mg (as calcium) | Oral |
| | Tablet 20 mg (as calcium) | Oral |
| | Tablet 40 mg (as calcium) | Oral |
| | Tablet 80 mg (as calcium) | Oral |
| Atovaquone | Oral suspension 750 mg per 5 mL, 210 mL | Oral |
| Atovaquone with proguanil | Tablet containing atovaquone 250 mg with proguanil hydrochloride 100 mg | Oral |
| Atropine | Eye drops containing atropine sulfate monohydrate 10 mg per mL, 15 mL | Application to the eye |
| | Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL | Injection |
| Auranofin | Capsule 3 mg | Oral |
| | Tablet 3 mg | Oral |
| Axitinib | Tablet 1 mg | Oral |
| | Tablet 5 mg | Oral |
| Azathioprine | Tablet 25 mg | Oral |
| | Tablet 50 mg | Oral |
| Azithromycin | Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL | Oral |
| | Tablet 500 mg (as dihydrate) | Oral |
| Baclofen | Tablet 10 mg | Oral |
| | Tablet 25 mg | Oral |
| Balsalazide | Capsule containing balsalazide sodium 750 mg | Oral |
| Baricitinib | Tablet 2 mg | Oral |
| | Tablet 4 mg | Oral |
| Beclometasone | Pressurised inhalation containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| | Pressurised inhalation containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| | Pressurised inhalation in breath actuated device containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| | Pressurised inhalation in breath actuated device containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| Beclometasone with formoterol | Pressurised inhalation containing beclometasone dipropionate 100 micrograms and formoterol fumarate dihydrate 6 micrograms per dose,120 dose | Inhalation by mouth |
| Benzathine benzylpenicillin | Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre‑filled syringe | Injection |
| | Injection containing 600,000 units benzathine benzylpenicillin tetrahydrate in 1.17 mL single use pre‑filled syringe | Injection |
| Benzatropine | Injection containing benzatropine mesilate 2 mg in 2 mL | Injection |
| | Tablet containing benzatropine mesilate 2 mg | Oral |
| Benzydamine | Mouth and throat rinse containing benzydamine hydrochloride 22.5 mg per 15 mL, 500 mL | Oral application |
| Benzylpenicillin | Powder for injection 3 g (as sodium) | Injection |
| | Powder for injection 600 mg (as sodium) | Injection |
| Betaine | Oral powder 180 g | Oral |
| Betamethasone | Cream 200 micrograms (as valerate) per g, 100 g | Application |
| | Cream 500 micrograms (as dipropionate) per g, 15 g | Application |
| | Cream 500 micrograms (as valerate) per g, 15 g | Application |
| | Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | Injection |
| | Ointment 500 micrograms (as dipropionate) per g, 15 g | Application |
| Betaxolol | Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL | Application to the eye |
| Bethanechol | Tablet containing bethanechol hydrochloride 10 mg | Oral |
| Bicalutamide | Tablet 50 mg | Oral |
| Bimatoprost | Eye drops 300 micrograms per mL, 3 mL | Application to the eye |
| | Eye drops 300 micrograms per mL, single dose units 0.4 mL, 30 | Application to the eye |
| Bimatoprost with timolol | Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, 3 mL | Application to the eye |
| | Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, single dose units 0.4 mL, 30 | Application to the eye |
| Binimetinib | Tablet 15 mg | Oral |
| Bisacodyl | Enemas 10 mg in 5 mL, 25 | Rectal |
| | Suppositories 10 mg, 10 | Rectal |
| | Suppositories 10 mg, 12 | Rectal |
| | Tablet 5 mg | Oral |
| Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral |
| | Tablet containing bisoprolol fumarate 2.5 mg | Oral |
| | Tablet containing bisoprolol fumarate 5 mg | Oral |
| Bivalirudin | Powder for I.V. injection 250 mg (as trifluoroacetate) | Injection |
| Brexpiprazole | Tablet 1 mg | Oral |
| | Tablet 2 mg | Oral |
| | Tablet 3 mg | Oral |
| | Tablet 4 mg | Oral |
| Brigatinib | Pack containing 7 tablets 90 mg and 21 tablets 180 mg | Oral |
| | Tablet 30 mg | Oral |
| | Tablet 90 mg | Oral |
| | Tablet 180 mg | Oral |
| Brimonidine | Eye drops containing brimonidine tartrate 1.5 mg per mL, 5 mL | Application to the eye |
| | Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL | Application to the eye |
| Brimonidine with timolol | Eye drops containing brimonidine tartrate 2 mg with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye |
| Brinzolamide | Eye drops 10 mg per mL, 5 mL | Application to the eye |
| Brinzolamide with brimonidine | Eye drops 10 mg brinzolamide with 2 mg brimonidine tartrate per mL, 5 mL | Application to the eye |
| Brinzolamide with timolol | Eye drops 10 mg brinzolamide with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye |
| Brivaracetam | Oral solution 10 mg per mL, 300 mL | Oral |
| | Tablet 100 mg | Oral |
| | Tablet 25 mg | Oral |
| | Tablet 50 mg | Oral |
| | Tablet 75 mg | Oral |
| Bromocriptine | Tablet 2.5 mg (as mesilate) | Oral |
| Budesonide | Nebuliser suspension 1 mg in 2 mL single dose units, 30 | Inhalation |
| | Nebuliser suspension 500 micrograms in 2 mL single dose units, 30 | Inhalation |
| | Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses | Inhalation by mouth |
| | Rectal foam 2 mg per application, 14 applications, aerosol 16.8 g, 2 | Rectal |
| Budesonide with formoterol | Powder for oral inhalation in breath actuated device containing budesonide 100 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses, 2 | Inhalation by mouth |
| | Pressurised inhalation containing budesonide 100 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses | Inhalation by mouth |
| | Pressurised inhalation containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth |
| | Pressurised inhalation containing budesonide 50 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses | Inhalation by mouth |
| Buprenorphine | Transdermal patch 10 mg | Transdermal |
| | Transdermal patch 15 mg | Transdermal |
| | Transdermal patch 20 mg | Transdermal |
| | Transdermal patch 25 mg | Transdermal |
| | Transdermal patch 30 mg | Transdermal |
| | Transdermal patch 40 mg | Transdermal |
| | Transdermal patch 5 mg | Transdermal |
| Bupropion | Tablet containing bupropion hydrochloride 150 mg (sustained release) | Oral |
| Busulfan | Tablet 2 mg | Oral |
| Cabergoline | Tablet 1 mg | Oral |
| | Tablet 2 mg | Oral |
| | Tablet 500 micrograms | Oral |
| Cabozantinib | Tablet 20 mg | Oral |
| | Tablet 40 mg | Oral |
| | Tablet 60 mg | Oral |
| Calcipotriol with betamethasone | Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g | Application |
| | Gel containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g | Application |
| | Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g | Application |
| Calcitonin salmon | Injection 100 I.U. in 1 mL | Injection |
| Calcitriol | Capsule 0.25 microgram | Oral |
| Calcium | Tablet 600 mg (as carbonate) | Oral |
| | Tablet, chewable, 500 mg (as carbonate) | Oral |
| Candesartan | Tablet containing candesartan cilexetil 16 mg | Oral |
| | Tablet containing candesartan cilexetil 32 mg | Oral |
| | Tablet containing candesartan cilexetil 4 mg | Oral |
| | Tablet containing candesartan cilexetil 8 mg | Oral |
| Candesartan with hydrochlorothiazide | Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg | Oral |
| | Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg | Oral |
| | Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg | Oral |
| Capecitabine | Tablet 150 mg | Oral |
| | Tablet 500 mg | Oral |
| Captopril | Oral solution 5 mg per mL, 95 mL | Oral |
| | Tablet 12.5 mg | Oral |
| | Tablet 25 mg | Oral |
| | Tablet 50 mg | Oral |
| Carbamazepine | Oral suspension 100 mg per 5 mL, 300 mL | Oral |
| | Tablet 100 mg | Oral |
| | Tablet 200 mg | Oral |
| | Tablet 200 mg (controlled release) | Oral |
| | Tablet 400 mg (controlled release) | Oral |
| Carbimazole | Tablet 5 mg | Oral |
| Carbohydrate, fat, vitamins, minerals and trace elements | Oral powder 400 g (Energivit) | Oral |
| Carbohydrate, fat, vitamins, minerals and trace elements and supplemented with arachidonic acid and docosahexaenoic acid | Sachets containing oral powder 43 g, 30 (basecal 200) | Oral |
| Carbomer | Eye gel 2 mg per g, 10 g | Application to the eye |
| | Eye gel 2 mg per g, single dose units 0.6 mL, 30 | Application to the eye |
| Carbomer 974 | Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30 | Application to the eye |
| Carmellose | Eye drops containing carmellose sodium 10 mg per mL, 15 mL | Application to the eye |
| | Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30 | Application to the eye |
| | Eye drops containing carmellose sodium 5 mg per mL, 10 mL | Application to the eye |
| | Eye drops containing carmellose sodium 5 mg per mL, 15 mL | Application to the eye |
| | Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30 | Application to the eye |
| Carmellose with glycerin | Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, 15 mL | Application to the eye |
| Carmustine | Implants 7.7 mg, 8 | Implantation |
| Carvedilol | Tablet 12.5 mg | Oral |
| | Tablet 25 mg | Oral |
| | Tablet 3.125 mg | Oral |
| | Tablet 6.25 mg | Oral |
| Cefaclor | Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL | Oral |
| | Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL | Oral |
| | Tablet (sustained release) 375 mg (as monohydrate) | Oral |
| Cefalexin | Capsule 250 mg (as monohydrate) | Oral |
| | Capsule 500 mg (as monohydrate) | Oral |
| | Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL | Oral |
| | Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL | Oral |
| Cefalotin | Powder for injection 1 g (as sodium) | Injection |
| Cefazolin | Powder for injection 1 g (as sodium) | Injection |
| | Powder for injection 2 g (as sodium) | Injection |
| | Powder for injection 500 mg (as sodium) | Injection |
| Cefepime | Powder for injection 1 g (as hydrochloride) | Injection |
| | Powder for injection 2 g (as hydrochloride) | Injection |
| Cefotaxime | Powder for injection 1 g (as sodium) | Injection |
| | Powder for injection 2 g (as sodium) | Injection |
| Ceftriaxone | Powder for injection 1 g (as sodium) | Injection |
| | Powder for injection 2 g (as sodium) | Injection |
| | Powder for injection 500 mg (as sodium) | Injection |
| Cefuroxime | Powder for oral suspension 125 mg (as axetil) per 5 mL, 100 mL | Oral |
| | Powder for oral suspension 125 mg (as axetil) per 5 mL, 70 mL | Oral |
| | Tablet 250 mg (as axetil) | Oral |
| Celecoxib | Capsule 100 mg | Oral |
| | Capsule 200 mg | Oral |
| Ceritinib | Capsule 150 mg | Oral |
| Certolizumab pegol | Injection 200 mg in 1 mL single use pre‑filled syringe | Injection |
| | Solution for injection 200 mg in 1 mL pre‑filled pen | Injection |
| Chlorambucil | Tablet 2 mg | Oral |
| Chloramphenicol | Eye drops 5 mg per mL, 10 mL | Application to the eye |
| Chlorpromazine | Injection containing chlorpromazine hydrochloride 50 mg in 2 mL | Injection |
| | Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL | Oral |
| | Tablet containing chlorpromazine hydrochloride 10 mg | Oral |
| | Tablet containing chlorpromazine hydrochloride 100 mg | Oral |
| | Tablet containing chlorpromazine hydrochloride 25 mg | Oral |
| Chlortalidone | Tablet 25 mg | Oral |
| Chorionic gonadotrophin | Injection set containing powder for injection 1,500 units, 3 and solvent 1 mL, 3 | Injection |
| Ciclesonide | Pressurised inhalation 160 micrograms per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| | Pressurised inhalation 80 micrograms per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| Ciclosporin | Capsule 10 mg | Oral |
| | Capsule 100 mg | Oral |
| | Capsule 25 mg | Oral |
| | Capsule 50 mg | Oral |
| | Oral liquid 100 mg per mL, 50 mL | Oral |
| Cimetidine | Tablet 400 mg | Oral |
| Cinacalcet | Tablet 30 mg (as hydrochloride) | Oral |
| | Tablet 60 mg (as hydrochloride) | Oral |
| | Tablet 90 mg (as hydrochloride) | Oral |
| Ciprofloxacin | Ear drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the ear |
| | Eye drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the eye |
| | Tablet 250 mg (as hydrochloride) | Oral |
| | Tablet 500 mg (as hydrochloride) | Oral |
| | Tablet 750 mg (as hydrochloride) | Oral |
| Citalopram | Tablet 10 mg (as hydrobromide) | Oral |
| | Tablet 20 mg (as hydrobromide) | Oral |
| | Tablet 40 mg (as hydrobromide) | Oral |
| Citrulline | Tablet 1 g, 300 (Citrulline Easy) | Oral |
| Citrulline with carbohydrate | Sachets of oral powder 4 g containing 1 g citrulline, 30 (Citrulline 1000) | Oral |
| Cladribine | Tablet 10 mg | Oral |
| Clarithromycin | Powder for oral liquid 250 mg per 5 mL, 50 mL | Oral |
| | Tablet 250 mg | Oral |
| Clindamycin | Capsule 150 mg (as hydrochloride) | Oral |
| Clobetasol | Shampoo containing clobetasol propionate 500 microgram per mL, 125 mL | Application |
| Clomifene | Tablet containing clomifene citrate 50 mg | Oral |
| Clomipramine | Tablet containing clomipramine hydrochloride 25 mg | Oral |
| Clonazepam | Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent) | Injection |
| | Oral liquid 2.5 mg per mL, 10 mL | Oral |
| | Tablet 2 mg | Oral |
| | Tablet 500 micrograms | Oral |
| Clonidine | Tablet containing clonidine hydrochloride 100 micrograms | Oral |
| | Tablet containing clonidine hydrochloride 150 micrograms | Oral |
| Clopidogrel | Tablet 75 mg (as besilate) | Oral |
| | Tablet 75 mg (as hydrogen sulfate) | Oral |
| Clopidogrel with aspirin | Tablet 75 mg (as hydrogen sulfate)‑100 mg | Oral |
| Cobimetinib | Tablet 20 mg | Oral |
| Codeine | Tablet containing codeine phosphate hemihydrate 30 mg | Oral |
| Codeine with paracetamol | Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg | Oral |
| Colchicine | Tablet 500 micrograms | Oral |
| Colestyramine | Sachets containing 4.7 g oral powder (equivalent to 4 g colestyramine), 50 | Oral |
| Cortisone | Tablet containing cortisone acetate 25 mg | Oral |
| | Tablet containing cortisone acetate 5 mg | Oral |
| Crizotinib | Capsule 200 mg | Oral |
| | Capsule 250 mg | Oral |
| Cromoglycic acid | Pressurised inhalation containing sodium cromoglycate 1 mg per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| | Pressurised inhalation containing sodium cromoglycate 5 mg per dose, 112 doses (CFC‑free formulation) | Inhalation by mouth |
| Cyclophosphamide | Tablet 50 mg (anhydrous) | Oral |
| Cyproterone | Tablet containing cyproterone acetate 100 mg | Oral |
| | Tablet containing cyproterone acetate 50 mg | Oral |
| Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral |
| | Capsule 150 mg (as mesilate) | Oral |
| | Capsule 75 mg (as mesilate) | Oral |
| Dabrafenib | Capsule 50 mg (as mesilate) | Oral |
| | Capsule 75 mg (as mesilate) | Oral |
| Dalteparin | Injection containing dalteparin sodium 10,000 I.U. (anti‑Xa) in 1 mL single dose pre‑filled syringe | Injection |
| | Injection containing dalteparin sodium 12,500 I.U. (anti‑Xa) in 0.5 mL single dose pre‑filled syringe | Injection |
| | Injection containing dalteparin sodium 15,000 I.U. (anti‑Xa) in 0.6 mL single dose pre‑filled syringe | Injection |
| | Injection containing dalteparin sodium 18,000 I.U. (anti‑Xa) in 0.72 mL single dose pre‑filled syringe | Injection |
| | Injection containing dalteparin sodium 2,500 I.U. (anti‑Xa) in 0.2 mL single dose pre‑filled syringe | Injection |
| | Injection containing dalteparin sodium 5,000 I.U. (anti‑Xa) in 0.2 mL single dose pre‑filled syringe | Injection |
| | Injection containing dalteparin sodium 7,500 I.U. (anti‑Xa) in 0.75 mL single dose pre‑filled syringe | Injection |
| Dantrolene | Capsule containing dantrolene sodium hemiheptahydrate 25 mg | Oral |
| | Capsule containing dantrolene sodium hemiheptahydrate 50 mg | Oral |
| Dapagliflozin | Tablet 10 mg (as propanediol monohydrate) | Oral |
| Dapagliflozin with metformin | Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | Oral |
| | Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride | Oral |
| | Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | Oral |
| Dapsone | Tablet 100 mg | Oral |
| | Tablet 25 mg | Oral |
| Dasatinib | Tablet 100 mg | Oral |
| | Tablet 20 mg | Oral |
| | Tablet 50 mg | Oral |
| | Tablet 70 mg | Oral |
| Degarelix | Powder for injection 120 mg (as acetate), 2, injection set | Injection |
| | Powder for injection 80 mg (as acetate), injection set | Injection |
| Denosumab | Injection 120 mg in 1.7 mL | Injection |
| | Injection 60 mg in 1 mL pre‑filled syringe | Injection |
| Desmopressin | Intranasal solution containing desmopressin acetate 100 micrograms per mL, 2.5 mL dropper bottle | Nasal |
| | Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL | Nasal |
| | Tablet containing desmopressin acetate 200 micrograms | Oral |
| | Wafer 120 micrograms (as acetate) | Sublingual |
| | Wafer 240 micrograms (as acetate) | Sublingual |
| Desvenlafaxine | Tablet (extended release) 100 mg (as succinate) | Oral |
| | Tablet (extended release) 50 mg (as succinate) | Oral |
| | Tablet (modified release) 100 mg | Oral |
| | Tablet (modified release) 100 mg (as benzoate) | Oral |
| | Tablet (modified release) 50 mg | Oral |
| | Tablet (modified release) 50 mg (as benzoate) | Oral |
| Dexamethasone | Eye drops 1 mg per mL, 5 mL | Application to the eye |
| | Intravitreal injection 700 micrograms | Implantation |
| | Tablet 4 mg | Oral |
| | Tablet 500 micrograms | Oral |
| Dexamethasone with framycetin and gramicidin | Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL | Application to the ear |
| Dexamfetamine | Tablet containing dexamfetamine sulfate 5 mg | Oral |
| Diazepam | Oral liquid 1 mg in 1 mL, 100 mL | Oral |
| | Tablet 2 mg | Oral |
| | Tablet 5 mg | Oral |
| Diclofenac | Suppository containing diclofenac sodium 100 mg | Rectal |
| | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral |
| | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral |
| Dicloxacillin | Capsule 250 mg (as sodium) | Oral |
| | Capsule 500 mg (as sodium) | Oral |
| Digoxin | Paediatric oral solution 50 micrograms per mL, 60 mL | Oral |
| | Tablet 250 micrograms | Oral |
| | Tablet 62.5 micrograms | Oral |
| Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral |
| | Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral |
| | Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral |
| | Tablet containing diltiazem hydrochloride 60 mg | Oral |
| Dimethyl fumarate | Capsule (modified release) 120 mg | Oral |
| | Capsule (modified release) 240 mg | Oral |
| Diphenoxylate with atropine | Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate monohydrate 25 micrograms | Oral |
| Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre‑filled syringe | Injection |
| Dipyridamole with aspirin | Capsule 200 mg (sustained release)‑25 mg | Oral |
| Disopyramide | Capsule 100 mg | Oral |
| Docosahexaenoic acid with carbohydrate | Sachets of oral powder 4 g containing 200 mg docosahexaenoic acid, 30 (docomega) | Oral |
| Domperidone | Tablet 10 mg | Oral |
| Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral |
| | Tablet containing donepezil hydrochloride 5 mg | Oral |
| Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye |
| Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye |
| Dosulepin | Capsule containing dosulepin hydrochloride 25 mg | Oral |
| | Tablet containing dosulepin hydrochloride 75 mg | Oral |
| Doxepin | Capsule 10 mg (as hydrochloride) | Oral |
| | Capsule 25 mg (as hydrochloride) | Oral |
| | Tablet 50 mg (as hydrochloride) | Oral |
| Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral |
| | Capsule 50 mg (as hyclate) (containing enteric coated pellets) | Oral |
| | Tablet 100 mg (as hyclate) | Oral |
| | Tablet 100 mg (as monohydrate) | Oral |
| | Tablet 50 mg (as hyclate) | Oral |
| | Tablet 50 mg (as monohydrate) | Oral |
| Dulaglutide | Injection 1.5 mg in 0.5 mL single dose pre‑filled pen | Injection |
| Duloxetine | Capsule 30 mg (as hydrochloride) | Oral |
| | Capsule 60 mg (as hydrochloride) | Oral |
| Dutasteride | Capsule 500 micrograms | Oral |
| Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral |
| Electrolyte replacement, oral | Oral rehydration salts containing glucose monohydrate 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10 | Oral |
| Eletriptan | Tablet 40 mg (as hydrobromide) | Oral |
| | Tablet 80 mg (as hydrobromide) | Oral |
| Empagliflozin | Tablet 10 mg | Oral |
| | Tablet 25 mg | Oral |
| Empagliflozin with linagliptin | Tablet containing 10 mg empagliflozin with 5 mg linagliptin | Oral |
| | Tablet containing 25 mg empagliflozin with 5 mg linagliptin | Oral |
| Empagliflozin with metformin | Tablet containing 12.5 mg empagliflozin with 1 g metformin hydrochloride | Oral |
| | Tablet containing 12.5 mg empagliflozin with 500 mg metformin hydrochloride | Oral |
| | Tablet containing 5 mg empagliflozin with 1 g metformin hydrochloride | Oral |
| | Tablet containing 5 mg empagliflozin with 500 mg metformin hydrochloride | Oral |
| Enalapril | Tablet containing enalapril maleate 10 mg | Oral |
| | Tablet containing enalapril maleate 20 mg | Oral |
| | Tablet containing enalapril maleate 5 mg | Oral |
| Enalapril with hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral |
| Encorafenib | Capsule 50 mg | Oral |
| | Capsule 75 mg | Oral |
| Enoxaparin | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti‑Xa) in 1 mL pre‑filled syringe | Injection |
| | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti‑Xa) in 0.2 mL pre‑filled syringe | Injection |
| | Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti‑Xa) in 0.4 mL pre‑filled syringe | Injection |
| | Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti‑Xa) in 0.6 mL pre‑filled syringe | Injection |
| | Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti‑Xa) in 0.8 mL pre‑filled syringe | Injection |
| Entacapone | Tablet 200 mg | Oral |
| Entrectinib | Capsule 200 mg | Oral |
| Enzalutamide | Capsule 40 mg | Oral |
| Eplerenone | Tablet 25 mg | Oral |
| | Tablet 50 mg | Oral |
| Eprosartan | Tablet 400 mg (as mesilate) | Oral |
| | Tablet 600 mg (as mesilate) | Oral |
| Eprosartan with hydrochlorothiazide | Tablet 600 mg eprosartan (as mesilate) with 12.5 mg hydrochlorothiazide | Oral |
| Eptifibatide | Solution for I.V. infusion 75 mg (as acetate) in 100 mL | Injection |
| | Solution for I.V. injection 20 mg (as acetate) in 10 mL | Injection |
| Erlotinib | Tablet 100 mg (as hydrochloride) | Oral |
| | Tablet 150 mg (as hydrochloride) | Oral |
| | Tablet 25 mg (as hydrochloride) | Oral |
| Ertugliflozin | Tablet 15 mg | Oral |
| | Tablet 5 mg | Oral |
| Ertugliflozin with metformin | Tablet containing 2.5 mg ertugliflozin with 1 g metformin hydrochloride | Oral |
| | Tablet containing 2.5 mg ertugliflozin with 500 mg metformin hydrochloride | Oral |
| | Tablet containing 7.5 mg ertugliflozin with 1 g metformin hydrochloride | Oral |
| | Tablet containing 7.5 mg ertugliflozin with 500 mg metformin hydrochloride | Oral |
| Ertugliflozin with sitagliptin | Tablet containing 15 mg ertugliflozin with 100 mg sitagliptin | Oral |
| | Tablet containing 5 mg ertugliflozin with 100 mg sitagliptin | Oral |
| Erythromycin | Capsule 250 mg (containing enteric coated pellets) | Oral |
| | Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | Oral |
| | Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | Oral |
| | Tablet 400 mg (as ethyl succinate) | Oral |
| Escitalopram | Oral solution 20 mg (as oxalate) per mL, 15 mL | Oral |
| | Tablet 10 mg (as oxalate) | Oral |
| | Tablet 20 mg (as oxalate) | Oral |
| Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | Oral |
| | Capsule (enteric) 40 mg (as magnesium) | Oral |
| | Tablet (enteric coated) 20 mg (as magnesium trihydrate) | Oral |
| | Tablet (enteric coated) 40 mg (as magnesium trihydrate) | Oral |
| Esomeprazole and clarithromycin and amoxicillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral |
| | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral |
| Essential amino acids formula | Oral powder 200 g (Essential Amino Acid Mix) | Oral |
| Essential amino acids formula with minerals and vitamin c | Oral powder 400 g (Dialamine) | Oral |
| Essential amino acids formula with vitamins and minerals | Sachets containing oral powder 12.5 g, 50 (EAA Supplement) | Oral |
| Estradiol | Pessary (modified release) 10 micrograms (as hemihydrate) | Vaginal |
| | Tablet 2 mg | Oral |
| | Tablet containing estradiol valerate 1 mg | Oral |
| | Tablet containing estradiol valerate 2 mg | Oral |
| | Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 | Transdermal |
| | Transdermal patches 1.17 mg, 8 | Transdermal |
| | Transdermal patches 1.5 mg (as hemihydrate), 8 | Transdermal |
| | Transdermal patches 1.56 mg, 8 | Transdermal |
| | Transdermal patches 2 mg, 4 | Transdermal |
| | Transdermal patches 3 mg (as hemihydrate), 8 | Transdermal |
| | Transdermal patches 3.8 mg, 4 | Transdermal |
| | Transdermal patches 390 micrograms, 8 | Transdermal |
| | Transdermal patches 5.7 mg, 4 | Transdermal |
| | Transdermal patches 585 micrograms, 8 | Transdermal |
| | Transdermal patches 7.6 mg, 4 | Transdermal |
| | Transdermal patches 750 micrograms (as hemihydrate), 8 | Transdermal |
| | Transdermal patches 780 micrograms, 8 | Transdermal |
| Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg | Oral |
| | Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg | Oral |
| Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate | Transdermal |
| | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate | Transdermal |
| Estradiol with dydrogesterone | Tablet 1 mg‑5 mg | Oral |
| Estradiol with norethisterone | Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 | Transdermal |
| | Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 | Transdermal |
| Estriol | Pessaries 500 micrograms, 15 | Vaginal |
| | Vaginal cream 1 mg per g, 15 g | Application |
| Etacrynic acid | Tablet 25 mg | Oral |
| Etanercept | Injection 50 mg in 1 mL single use auto‑injector, 4 | Injection |
| | Injection set containing 4 vials powder for injection 25 mg and 4 pre‑filled syringes solvent 1 mL | Injection |
| | Injections 50 mg in 1 mL single use pre‑filled syringes, 4 | Injection |
| Ethosuximide | Capsule 250 mg | Oral |
| | Oral solution 250 mg per 5 mL, 200 mL | Oral |
| Etonogestrel | Subcutaneous implant 68 mg | Implantation |
| Etoposide | Capsule 100 mg | Oral |
| | Capsule 50 mg | Oral |
| Everolimus | Tablet 0.25 mg | Oral |
| | Tablet 0.5 mg | Oral |
| | Tablet 0.75 mg | Oral |
| | Tablet 1 mg | Oral |
| | Tablet 10 mg | Oral |
| | Tablet 2.5 mg | Oral |
| | Tablet 5 mg | Oral |
| | Tablet, dispersible, 2 mg | Oral |
| | Tablet, dispersible, 3 mg | Oral |
| | Tablet, dispersible, 5 mg | Oral |
| Evolocumab | Injection 140 mg in 1 mL single use pre‑filled pen | Injection |
| | Injection 420 mg in 3.5 mL single use pre‑filled cartridge | Injection |
| Exemestane | Tablet 25 mg | Oral |
| Exenatide | Injection (modified release) 2 mg single dose pre‑filled pen | Injection |
| | Injection solution 10 micrograms per dose in pre‑filled pen, 60 doses | Injection |
| | Injection solution 5 micrograms per dose in pre‑filled pen, 60 doses | Injection |
| Ezetimibe | Tablet 10 mg | Oral |
| Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral |
| | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral |
| | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral |
| | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral |
| Ezetimibe with atorvastatin | Tablet 10 mg‑10 mg | Oral |
| | Tablet 10 mg‑20 mg | Oral |
| | Tablet 10 mg‑40 mg | Oral |
| | Tablet 10 mg‑80 mg | Oral |
| Ezetimibe with simvastatin | Tablet 10 mg‑10 mg | Oral |
| | Tablet 10 mg‑20 mg | Oral |
| | Tablet 10 mg‑40 mg | Oral |
| | Tablet 10 mg‑80 mg | Oral |
| Famciclovir | Tablet 125 mg | Oral |
| | Tablet 250 mg | Oral |
| | Tablet 500 mg | Oral |
| Famotidine | Tablet 20 mg | Oral |
| | Tablet 40 mg | Oral |
| Febuxostat | Tablet 80 mg | Oral |
| Felodipine | Tablet 10 mg (extended release) | Oral |
| | Tablet 2.5 mg (extended release) | Oral |
| | Tablet 5 mg (extended release) | Oral |
| Fenofibrate | Tablet 145 mg | Oral |
| | Tablet 48 mg | Oral |
| Fentanyl | Lozenge 1200 micrograms (as citrate) | Buccal |
| | Lozenge 1600 micrograms (as citrate) | Buccal |
| | Lozenge 200 micrograms (as citrate) | Buccal |
| | Lozenge 400 micrograms (as citrate) | Buccal |
| | Lozenge 600 micrograms (as citrate) | Buccal |
| | Lozenge 800 micrograms (as citrate) | Buccal |
| | Tablet (orally disintegrating) 100 micrograms (as citrate) | Buccal |
| | Tablet (orally disintegrating) 200 micrograms (as citrate) | Buccal |
| | Tablet (orally disintegrating) 400 micrograms (as citrate) | Buccal |
| | Tablet (orally disintegrating) 600 micrograms (as citrate) | Buccal |
| | Tablet (orally disintegrating) 800 micrograms (as citrate) | Buccal |
| | Tablet (sublingual) 100 micrograms (as citrate) | Sublingual |
| | Tablet (sublingual) 200 micrograms (as citrate) | Sublingual |
| | Tablet (sublingual) 300 micrograms (as citrate) | Sublingual |
| | Tablet (sublingual) 400 micrograms (as citrate) | Sublingual |
| | Tablet (sublingual) 600 micrograms (as citrate) | Sublingual |
| | Tablet (sublingual) 800 micrograms (as citrate) | Sublingual |
| | Transdermal patch 1.28 mg | Transdermal |
| | Transdermal patch 10.20 mg | Transdermal |
| | Transdermal patch 12.375 mg | Transdermal |
| | Transdermal patch 12.6 mg | Transdermal |
| | Transdermal patch 16.5 mg | Transdermal |
| | Transdermal patch 16.8 mg | Transdermal |
| | Transdermal patch 2.063 mg | Transdermal |
| | Transdermal patch 2.1 mg | Transdermal |
| | Transdermal patch 2.55 mg | Transdermal |
| | Transdermal patch 4.125 mg | Transdermal |
| | Transdermal patch 4.2 mg | Transdermal |
| | Transdermal patch 5.10 mg | Transdermal |
| | Transdermal patch 7.65 mg | Transdermal |
| | Transdermal patch 8.25 mg | Transdermal |
| | Transdermal patch 8.4 mg | Transdermal |
| Ferric carboxymaltose | Injection 1000 mg (iron) in 20 mL | Injection |
| | Injection 500 mg (iron) in 10 mL | Injection |
| Ferric derisomaltose | Injection 500 mg (iron) in 5 mL | Injection |
| | Injection 1000 mg (iron) in 10 mL | Injection |
| Ferrous fumarate | Tablet 200 mg (equivalent to 65.7 mg iron) | Oral |
| Ferrous fumarate with folic acid | Tablet 310 mg (equivalent to 100 mg iron)‑350 micrograms | Oral |
| Ferrous sulfate | Oral liquid containing 30 mg ferrous sulfate heptahydrate per mL, 250 mL | Oral |
| Fingolimod | Capsule 250 micrograms (as hydrochloride) | Oral |
| | Capsule 500 micrograms (as hydrochloride) | Oral |
| Flecainide | Tablet containing flecainide acetate 100 mg | Oral |
| | Tablet containing flecainide acetate 50 mg | Oral |
| Flucloxacillin | Capsule 250 mg (as sodium monohydrate) | Oral |
| | Capsule 500 mg (as sodium monohydrate) | Oral |
| | Powder for injection 1 g (as sodium monohydrate) | Injection |
| | Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
| | Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
| Fluconazole | Capsule 100 mg | Oral |
| | Capsule 200 mg | Oral |
| | Capsule 50 mg | Oral |
| | Powder for oral suspension 50 mg in 5 mL, 35 mL | Oral |
| | Solution for I.V. infusion 200 mg in 100 mL | Injection |
| | Solution for I.V. infusion 400 mg in 200 mL | Injection |
| Fludarabine | Tablet containing fludarabine phosphate 10 mg | Oral |
| Fludrocortisone | Tablet containing fludrocortisone acetate 100 micrograms | Oral |
| Fluorometholone | Eye drops 1 mg per mL, 5 mL | Application to the eye |
| | Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL | Application to the eye |
| Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral |
| | Tablet, dispersible, 20 mg (as hydrochloride) | Oral |
| Flupentixol decanoate | Oily I.M. injection 100 mg in 1 mL | Injection |
| | Oily I.M. injection 20 mg in 1 mL | Injection |
| Flutamide | Tablet 250 mg | Oral |
| Fluticasone furoate | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses | Inhalation by mouth |
| Fluticasone furoate with umeclidinium and vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth |
| Fluticasone furoate with vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth |
| Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses | Inhalation by mouth |
| | Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| | Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth |
| | Pressurised inhalation containing fluticasone propionate 250 micrograms with formoterol fumarate dihydrate 10 micrograms per dose, 120 doses | Inhalation by mouth |
| | Pressurised inhalation containing fluticasone propionate 50 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth |
| Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth |
| | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| Fluvastatin | Tablet (prolonged release) 80 mg (as sodium) | Oral |
| Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral |
| | Tablet containing fluvoxamine maleate 50 mg | Oral |
| Folic acid | Tablet 5 mg | Oral |
| | Tablet 500 micrograms | Oral |
| Folinic acid | Injection containing calcium folinate equivalent to 100 mg folinic acid in 10 mL | Injection |
| | Injection containing calcium folinate equivalent to 300 mg folinic acid in 30 mL | Injection |
| | Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL | Injection |
| | Tablet containing calcium folinate equivalent to 15 mg folinic acid | Oral |
| Follitropin alfa | Injection 150 I.U. in 0.25 mL pre‑filled pen | Injection |
| | Injection 225 I.U. in 0.375 mL pre‑filled pen | Injection |
| | Injection 300 I.U. in 0.5 mL multi‑dose cartridge | Injection |
| | Injection 450 I.U. in 0.75 mL multi‑dose cartridge | Injection |
| | Injection 75 I.U. in 0.125 mL pre‑filled pen | Injection |
| | Injection 900 I.U. in 1.5 mL multi‑dose cartridge | Injection |
| Follitropin beta | Solution for injection 300 I.U. in 0.36 mL multi‑dose cartridge | Injection |
| | Solution for injection 600 I.U. in 0.72 mL multi‑dose cartridge | Injection |
| | Solution for injection 900 I.U. in 1.08 mL multi‑dose cartridge | Injection |
| Fondaparinux | Injection containing fondaparinux sodium 2.5 mg in 0.5 mL single dose pre‑filled syringe | Injection |
| Formoterol | Capsule containing powder for oral inhalation containing formoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer) | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth |
| | Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 6 micrograms per dose, 60 doses | Inhalation by mouth |
| Fosaprepitant | Powder for I.V. infusion 150 mg | Injection |
| Fosinopril | Tablet containing fosinopril sodium 10 mg | Oral |
| | Tablet containing fosinopril sodium 20 mg | Oral |
| Fosinopril with hydrochlorothiazide | Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | Oral |
| Framycetin | Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL | Application to the eye/ear |
| Furosemide | Injection 20 mg in 2 mL | Injection |
| | Oral solution 10 mg per mL, 30 mL | Oral |
| | Tablet 20 mg | Oral |
| | Tablet 40 mg | Oral |
| | Tablet 500 mg | Oral |
| Fusidic acid | Tablet containing sodium fusidate 250 mg | Oral |
| Gabapentin | Capsule 100 mg | Oral |
| | Capsule 300 mg | Oral |
| | Capsule 400 mg | Oral |
| | Tablet 600 mg | Oral |
| | Tablet 800 mg | Oral |
| Galantamine | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral |
| | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral |
| | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral |
| Gefitinib | Tablet 250 mg | Oral |
| Gemfibrozil | Tablet 600 mg | Oral |
| Gentamicin | Eye drops 3 mg (as sulfate) per mL, 5 mL | Application to the eye |
| | Injection 80 mg (as sulfate) in 2 mL | Injection |
| Glatiramer | Injection containing glatiramer acetate 40 mg in 1 mL single dose pre‑filled syringe | Injection |
| Glecaprevir with pibrentasvir | Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir | Oral |
| Glibenclamide | Tablet 5 mg | Oral |
| Gliclazide | Tablet 30 mg (modified release) | Oral |
| | Tablet 60 mg (modified release) | Oral |
| | Tablet 80 mg | Oral |
| Glimepiride | Tablet 1 mg | Oral |
| | Tablet 2 mg | Oral |
| | Tablet 3 mg | Oral |
| | Tablet 4 mg | Oral |
| Glipizide | Tablet 5 mg | Oral |
| Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | Injection |
| Glucose and ketone indicator‑urine | Test strips, 50 (Keto‑Diastix) | For external use |
| Glucose indicator‑urine | Test strips, 50 (Diastix) | For external use |
| Glyceryl trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | Sublingual |
| | Transdermal patch 18 mg | Transdermal |
| | Transdermal patch 25 mg | Transdermal |
| | Transdermal patch 36 mg | Transdermal |
| | Transdermal patch 50 mg | Transdermal |
| | Transdermal patch 54 mg | Transdermal |
| Glycine with carbohydrate | Sachets of oral powder 4 g containing 500 mg glycine, 30 (Glycine500) | Oral |
| Glycomacropeptide and essential amino acid formula with vitamins, minerals, and low in tyrosine and phenylalanine | Sachets containing oral powder 31 g, 30 (Tylactin Build 20) | Oral |
| | Sachets containing oral powder 35 g, 30 (TYR Sphere20) | Oral |
| Glycomacropeptide and essential amino acids with vitamins and minerals | Bars 81 g, 14 (Tylactin Complete) | Oral |
| | Bars 81 g, 7 (Camino Pro Complete) | Oral |
| | Oral liquid 250 mL, 30 (PKU Glytactin RTD 15 Lite) | Oral |
| | Oral liquid 250 mL, 30 (PKU Glytactin RTD 15) | Oral |
| | Oral liquid 250 mL, 30 (Tylactin RTD) | Oral |
| | Sachets containing oral powder 16 g, 60 (PKU Build 10) | Oral |
| | Sachets containing oral powder 20 g, 60 (PKU Restore) | Oral |
| | Sachets containing oral powder 32 g, 30 (PKU Build 20) | Oral |
| | Sachets containing oral powder 49 g, 30 (Camino Pro Bettermilk) | Oral |
| | Sachets containing oral powder 51 g, 30 (PKU Bettermilk Lite) | Oral |
| Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine | Oral liquid 250 mL, 18 (PKU GMPro LQ) | Oral |
| | Sachets containing oral powder 27 g, 30 (PKU Sphere15) | Oral |
| | Sachets containing oral powder 35 g, 30 (PKU Sphere20) | Oral |
| Glycopyrronium | Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler) | Inhalation by mouth |
| Golimumab | Injection 100 mg in 1 mL single use pre‑filled pen | Injection |
| | Injection 50 mg in 0.5 mL single use pre‑filled pen | Injection |
| | Injection 50 mg in 0.5 mL single use pre‑filled syringe | Injection |
| Goserelin | Subcutaneous implant (long acting) 10.8 mg (as acetate) in pre‑filled injection syringe | Implantation |
| | Subcutaneous implant 3.6 mg (as acetate) in pre‑filled injection syringe | Implantation |
| Goserelin and bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/oral |
| | Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 84 tablets bicalutamide 50 mg | Implantation/oral |
| | Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/oral |
| Granisetron | Concentrated injection 3 mg (as hydrochloride) in 3 mL | Injection |
| | Tablet 2 mg (as hydrochloride) | Oral |
| Grazoprevir with elbasvir | Tablet containing grazoprevir 100 mg with elbasvir 50 mg | Oral |
| Griseofulvin | Tablet 125 mg | Oral |
| | Tablet 500 mg | Oral |
| Guanfacine | Tablet 1 mg (as hydrochloride) | Oral |
| | Tablet 2 mg (as hydrochloride) | Oral |
| | Tablet 3 mg (as hydrochloride) | Oral |
| | Tablet 4 mg (as hydrochloride) | Oral |
| Guselkumab | Injection 100 mg in 1 mL single use pre‑filled syringe | Injection |
| Haloperidol | Injection 5 mg in 1 mL | Injection |
| | Oral solution 2 mg per mL, 100 mL | Oral |
| | Tablet 1.5 mg | Oral |
| | Tablet 5 mg | Oral |
| | Tablet 500 micrograms | Oral |
| Haloperidol decanoate | I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule | Injection |
| | I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule | Injection |
| Heparin | Injection (preservative‑free) 5,000 I.U. (as sodium) in 5 mL | Injection |
| | Injection 5,000 units (as sodium) in 0.2 mL | Injection |
| High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 200 mL, 32 (KetoCal 4:1 LQ) | Oral |
| | Oral powder 300 g (KetoCal 3:1) | Oral |
| | Oral powder 300 g (KetoCal 4:1) | Oral |
| | Oral semi‑solid 100 g, 48 (Keyo) | Oral |
| Hyaluronic acid | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | Application to the eye |
| | Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | Application to the eye |
| Hydralazine | Tablet containing hydralazine hydrochloride 25 mg | Oral |
| | Tablet containing hydralazine hydrochloride 50 mg | Oral |
| Hydrochlorothiazide | Tablet 25 mg | Oral |
| Hydrochlorothiazide with amiloride | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | Oral |
| Hydrocortisone | Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application |
| | Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g | Application to the eye |
| | Injection 100 mg (as sodium succinate) with 2 mL solvent | Injection |
| | Injection 250 mg (as sodium succinate) with 2 mL solvent | Injection |
| | Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application |
| | Rectal foam containing hydrocortisone acetate 90 mg per applicatorful, 14 applications, aerosol 21.1 g | Rectal |
| | Tablet 20 mg | Oral |
| | Tablet 4 mg | Oral |
| Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection |
| | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection |
| | Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 200 mL | Oral |
| | Tablet (modified release) containing hydromorphone hydrochloride 16 mg | Oral |
| | Tablet (modified release) containing hydromorphone hydrochloride 32 mg | Oral |
| | Tablet (modified release) containing hydromorphone hydrochloride 4 mg | Oral |
| | Tablet (modified release) containing hydromorphone hydrochloride 64 mg | Oral |
| | Tablet (modified release) containing hydromorphone hydrochloride 8 mg | Oral |
| | Tablet containing hydromorphone hydrochloride 2 mg | Oral |
| | Tablet containing hydromorphone hydrochloride 4 mg | Oral |
| | Tablet containing hydromorphone hydrochloride 8 mg | Oral |
| Hydroxocobalamin | Injection 1 mg (as acetate) in 1 mL | Injection |
| | Injection 1 mg (as chloride) in 1 mL | Injection |
| Hydroxycarbamide | Capsule 500 mg | Oral |
| Hydroxychloroquine | Tablet containing hydroxychloroquine sulfate 200 mg | Oral |
| Hydroxyethyl starch 130/0.4 | I.V. infusion 30 g per 500 mL, 500 mL | Injection |
| Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | Injection |
| Hypromellose | 0.3% w/v eye drops, 10 mL (preservative free) | Application to the eye |
| | Eye drops 3 mg per mL, 10 mL | Application to the eye |
| | Eye drops 5 mg per mL, 15 mL | Application to the eye |
| Hypromellose with carbomer 980 | Ocular lubricating gel 3 mg‑2 mg per g, 10 g | Application to the eye |
| Hypromellose with dextran | Eye drops containing 3 mg hypromellose 2900 with 1 mg dextran 70 per mL, single dose units 0.4 mL, 28 | Application to the eye |
| | Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye |
| Ibandronic acid | Tablet 50 mg (as ibandronate sodium monohydrate) | Oral |
| Ibrutinib | Capsule 140 mg | Oral |
| Ibuprofen | Tablet 400 mg | Oral |
| Icatibant | Injection 30 mg (as acetate) in 3 mL single use pre‑filled syringe | Injection |
| Idelalisib | Tablet 100 mg | Oral |
| | Tablet 150 mg | Oral |
| Imatinib | Capsule 100 mg (as mesilate) | Oral |
| | Capsule 400 mg (as mesilate) | Oral |
| | Tablet 100 mg (as mesilate) | Oral |
| | Tablet 400 mg (as mesilate) | Oral |
| Imipramine | Tablet containing imipramine hydrochloride 10 mg | Oral |
| | Tablet containing imipramine hydrochloride 25 mg | Oral |
| | Tablet containing imipramine hydrochloride 25 mg USP | Oral |
| Imiquimod | Cream 50 mg per g, 2 g, 2 | Application |
| | Cream 50 mg per g, 250 mg single use sachets, 12 | Application |
| Indacaterol | Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth |
| | Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth |
| Indacaterol with glycopyrronium | Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler) | Inhalation by mouth |
| Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral |
| | Tablet containing indapamide hemihydrate 2.5 mg | Oral |
| Indometacin | Capsule 25 mg | Oral |
| | Suppository 100 mg | Rectal |
| Insect allergen extract‑honey bee venom | Injection set containing 550 micrograms | Injection |
| | Injection set containing 550 micrograms with diluent | Injection |
| Insect allergen extract‑paper wasp venom | Injection set containing 550 micrograms | Injection |
| | Injection set containing 550 micrograms with diluent | Injection |
| Insect allergen extract‑yellow jacket venom | Injection set containing 550 micrograms | Injection |
| | Injection set containing 550 micrograms with diluent | Injection |
| Insulin aspart | Injection (human analogue) (fast acting) 100 units per mL, 10 mL vial | Injection |
| | Injection (human analogue) 100 units per mL, 10 mL vial | Injection |
| | Injections (human analogue) (fast acting), pre‑filled pen, 100 units per mL, 3 mL, 5 | Injection |
| | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Insulin aspart with insulin aspart protamine suspension | Injections (human analogue), cartridges, 30 units‑70 units per mL, 3 mL, 5 | Injection |
| Insulin degludec with insulin aspart | Injections, cartridges, 70 units‑30 units per mL, 3 mL, 5 | Injection |
| | Injections, pre‑filled pen, 70 units‑30 units per mL, 3 mL, 5 | Injection |
| Insulin detemir | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Insulin glargine | Injections (human analogue), cartridge, 300 units per mL, 1.5 mL, 3 | Injection |
| | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| | Injections (human analogue), cartridges, 300 units per mL, 1.5 mL, 5 | Injection |
| Insulin glulisine | Injection (human analogue) 100 units per mL, 10 mL | Injection |
| | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Insulin isophane | Injection (human) 100 units per mL, 10 mL | Injection |
| | Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Insulin lispro | Injection (human analogue) 100 units per mL, 10 mL vial | Injection |
| | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| | Injections (human analogue), pre‑filled pen, 200 units per mL, 3 mL, 5 | Injection |
| Insulin lispro with insulin lispro protamine suspension | Injections (human analogue), cartridges, 25 units‑75 units per mL, 3 mL, 5 | Injection |
| | Injections (human analogue), cartridges, 50 units‑50 units per mL, 3 mL, 5 | Injection |
| Insulin neutral | Injection (human) 100 units per mL, 10 mL | Injection |
| | Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Insulin neutral with insulin isophane | Injection (human) 30 units‑70 units per mL, 10 mL | Injection |
| | Injections (human), cartridges, 30 units‑70 units per mL, 3 mL, 5 | Injection |
| | Injections (human), cartridges, 50 units‑50 units per mL, 3 mL, 5 | Injection |
| Interferon alfa‑2a | Injection 3,000,000 I.U. in 0.5 mL single dose pre‑filled syringe | Injection |
| | Injection 9,000,000 I.U. in 0.5 mL single dose pre‑filled syringe | Injection |
| Interferon beta‑1a | Injection 30 micrograms (6,000,000 I.U.) in 0.5 mL single dose pre‑filled syringe | Injection |
| | Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose autoinjector | Injection |
| | Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose pre‑filled syringe | Injection |
| | Solution for injection 132 micrograms in 1.5 mL multidose cartridge | Injection |
| Interferon beta‑1b | Injection set including 1 vial powder for injection 8,000,000 I.U. (250 micrograms) and solvent | Injection |
| Ipratropium | Nebuliser solution containing ipratropium bromide 250 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation |
| | Nebuliser solution containing ipratropium bromide 500 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation |
| | Pressurised inhalation containing ipratropium bromide monohydrate 21 micrograms per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| Irbesartan | Tablet 150 mg | Oral |
| | Tablet 300 mg | Oral |
| | Tablet 75 mg | Oral |
| Irbesartan with hydrochlorothiazide | Tablet 150 mg‑12.5 mg | Oral |
| | Tablet 300 mg‑12.5 mg | Oral |
| | Tablet 300 mg‑25 mg | Oral |
| Iron polymaltose complex | Injection 100 mg (iron) in 2 mL | Injection |
| Iron sucrose | Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL | Injection |
| Isoleucine with carbohydrate | Sachets of oral powder 4 g containing 1 g isoleucine, 30 (Isoleucine 1000) | Oral |
| | Sachets of oral powder 4 g containing 50 mg isoleucine, 30 (Isoleucine 50) | Oral |
| Isoniazid | Tablet 100 mg | Oral |
| Isosorbide dinitrate | Tablet 5 mg (sublingual) | Oral |
| Isosorbide mononitrate | Tablet 120 mg (sustained release) | Oral |
| | Tablet 60 mg (sustained release) | Oral |
| Isotretinoin | Capsule 10 mg | Oral |
| | Capsule 20 mg | Oral |
| | Capsule 30 mg | Oral |
| | Capsule 40 mg | Oral |
| | Capsule 5 mg | Oral |
| Itraconazole | Capsule 100 mg | Oral |
| | Capsule 50 mg | Oral |
| Ivabradine | Tablet 5 mg (as hydrochloride) | Oral |
| | Tablet 7.5 mg (as hydrochloride) | Oral |
| Ivermectin | Tablet 3 mg | Oral |
| Ixekizumab | Injection 80 mg in 1 mL single dose pre‑filled pen | Injection |
| Ketoconazole | Cream 20 mg per g, 30 g | Application |
| | Shampoo 20 mg per g, 60 mL | Application |
| Ketoprofen | Capsule 200 mg (sustained release) | Oral |
| Labetalol | Tablet containing labetalol hydrochloride 100 mg | Oral |
| | Tablet containing labetalol hydrochloride 200 mg | Oral |
| Lacosamide | Oral solution 10 mg per mL, 200 mL | Oral |
| | Tablet 100 mg | Oral |
| | Tablet 150 mg | Oral |
| | Tablet 200 mg | Oral |
| | Tablet 50 mg | Oral |
| Lamotrigine | Tablet 100 mg | Oral |
| | Tablet 200 mg | Oral |
| | Tablet 25 mg | Oral |
| | Tablet 5 mg | Oral |
| | Tablet 50 mg | Oral |
| Lansoprazole | Capsule 15 mg | Oral |
| | Capsule 30 mg | Oral |
| | Tablet 15 mg (orally disintegrating) | Oral |
| | Tablet 30 mg (orally disintegrating) | Oral |
| Lanthanum | Tablet, chewable, 1000 mg (as carbonate hydrate) | Oral |
| | Tablet, chewable, 500 mg (as carbonate hydrate) | Oral |
| | Tablet, chewable, 750 mg (as carbonate hydrate) | Oral |
| Lapatinib | Tablet 250 mg (as ditosilate monohydrate) | Oral |
| Latanoprost | Eye drops 50 micrograms per mL, 2.5 mL | Application to the eye |
| Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye |
| Ledipasvir with sofosbuvir | Tablet containing 90 mg ledipasvir with 400 mg sofosbuvir | Oral |
| Leflunomide | Tablet 10 mg | Oral |
| | Tablet 20 mg | Oral |
| Lenvatinib | Capsule 10 mg (as mesilate) | Oral |
| | Capsule 4 mg (as mesilate) | Oral |
| Lercanidipine | Tablet containing lercanidipine hydrochloride 10 mg | Oral |
| | Tablet containing lercanidipine hydrochloride 20 mg | Oral |
| Lercanidipine with enalapril | Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg | Oral |
| | Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg | Oral |
| Letrozole | Tablet 2.5 mg | Oral |
| Leuprorelin | I.M. injection (3 month modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre‑filled dual‑chamber syringe | Injection |
| | I.M. injection (modified release), powder for injection containing leuprorelin acetate 22.5 mg with diluent in pre‑filled dual‑chamber syringe | Injection |
| | I.M. injection (modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre‑filled dual‑chamber syringe | Injection |
| | I.M. injection (modified release), powder for injection containing leuprorelin acetate 45 mg with diluent in pre‑filled dual‑chamber syringe | Injection |
| | I.M. injection (modified release), powder for injection containing leuprorelin acetate 7.5 mg with diluent in pre‑filled dual‑chamber syringe | Injection |
| | Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 22.5 mg, injection set | Injection |
| | Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 30 mg, injection set | Injection |
| | Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 45 mg, injection set | Injection |
| | Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 7.5 mg, injection set | Injection |
| Leuprorelin and bicalutamide | Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 28 tablets bicalutamide 50 mg | Injection/oral |
| | Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 84 tablets bicalutamide 50 mg | Injection/oral |
| | Pack containing 1 syringe containing leuprorelin 7.5 mg (as acetate) and 28 tablets bicalutamide 50 mg | Injection/oral |
| Levetiracetam | Oral solution 100 mg per mL, 300 mL | Oral |
| | Tablet 1 g | Oral |
| | Tablet 250 mg | Oral |
| | Tablet 500 mg | Oral |
| Levodopa with benserazide | Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral |
| | Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) (sustained release) | Oral |
| | Capsule containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) | Oral |
| | Capsule containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) | Oral |
| | Dispersible tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral |
| | Dispersible tablet containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) | Oral |
| | Tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral |
| | Tablet containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) | Oral |
| Levodopa with carbidopa | Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg per mL, 100 mL | Intra‑intestinal |
| | Tablet (modified release) 200 mg‑50 mg (as monohydrate) | Oral |
| | Tablet (prolonged release) 200 mg‑50 mg | Oral |
| | Tablet 100 mg‑25 mg (as monohydrate) | Oral |
| | Tablet 250 mg‑25 mg (as monohydrate) | Oral |
| Levodopa with carbidopa and entacapone | Tablet 100 mg‑25 mg (as monohydrate)‑200 mg | Oral |
| | Tablet 125 mg‑31.25 mg (as monohydrate)‑200 mg | Oral |
| | Tablet 150 mg‑37.5 mg (as monohydrate)‑200 mg | Oral |
| | Tablet 200 mg‑50 mg (as monohydrate)‑200 mg | Oral |
| | Tablet 50 mg‑12.5 mg (as monohydrate)‑200 mg | Oral |
| | Tablet 75 mg‑18.75 mg (as monohydrate)‑200 mg | Oral |
| Levonorgestrel | Intrauterine drug delivery system 19.5 mg | Intrauterine |
| | Intrauterine drug delivery system 52 mg | intrauterine |
| | Tablets 30 micrograms, 28 | Oral |
| Levonorgestrel with ethinylestradiol | Pack containing 21 tablets 100 micrograms‑20 micrograms and 7 inert tablets | Oral |
| | Pack containing 21 tablets 125 micrograms‑50 micrograms and 7 inert tablets | Oral |
| | Pack containing 21 tablets 150 micrograms‑30 micrograms and 7 inert tablets | Oral |
| | Pack containing 6 tablets 50 micrograms‑30 micrograms, 5 tablets 75 micrograms‑40 micrograms, 10 tablets 125 micrograms‑30 micrograms and 7 inert tablets | Oral |
| Levothyroxine | Tablet containing 100 micrograms anhydrous levothyroxine sodium | Oral |
| | Tablet containing 200 micrograms anhydrous levothyroxine sodium | Oral |
| | Tablet containing 50 micrograms anhydrous levothyroxine sodium | Oral |
| | Tablet containing 75 micrograms anhydrous levothyroxine sodium | Oral |
| Lidocaine | Infusion containing lidocaine hydrochloride 500 mg in 5 mL | Injection |
| Linagliptin | Tablet 5 mg | Oral |
| Linagliptin with metformin | Tablet containing 2.5 mg linagliptin with 1000 mg metformin hydrochloride | Oral |
| | Tablet containing 2.5 mg linagliptin with 500 mg metformin hydrochloride | Oral |
| | Tablet containing 2.5 mg linagliptin with 850 mg metformin hydrochloride | Oral |
| Lincomycin | Injection 600 mg (as hydrochloride monohydrate) in 2 mL | Injection |
| Liothyronine | Tablet containing liothyronine sodium 20 micrograms | Oral |
| Lisdexamfetamine | Capsule containing lisdexamfetamine dimesilate 20 mg | Oral |
| | Capsule containing lisdexamfetamine dimesilate 30 mg | Oral |
| | Capsule containing lisdexamfetamine dimesilate 40 mg | Oral |
| | Capsule containing lisdexamfetamine dimesilate 50 mg | Oral |
| | Capsule containing lisdexamfetamine dimesilate 60 mg | Oral |
| | Capsule containing lisdexamfetamine dimesilate 70 mg | Oral |
| Lisinopril | Tablet 10 mg | Oral |
| | Tablet 20 mg | Oral |
| | Tablet 5 mg | Oral |
| Lithium | Tablet containing lithium carbonate 250 mg | Oral |
| | Tablet containing lithium carbonate 450 mg (slow release) | Oral |
| Loperamide | Capsule containing loperamide hydrochloride 2 mg | Oral |
| Lorlatinib | Tablet 25 mg | Oral |
| | Tablet 100 mg | Oral |
| Losartan | Tablet containing losartan potassium 25 mg | Oral |
| | Tablet containing losartan potassium 50 mg | Oral |
| Lurasidone | Tablet containing lurasidone hydrochloride 40 mg | Oral |
| | Tablet containing lurasidone hydrochloride 80 mg | Oral |
| Macrogol 3350 | Oral liquid 13.125 g in 25 mL with electrolytes, 500 mL | Oral |
| | Powder for oral solution 510 g | Oral |
| | Sachets containing powder for oral solution 13.125 g with electrolytes, 30 | Oral |
| Magnesium | Tablet 37.4 mg (as aspartate dihydrate) | Oral |
| Medroxyprogesterone | Injection containing medroxyprogesterone acetate 150 mg in 1 mL | Injection |
| | Tablet containing medroxyprogesterone acetate 10 mg | Oral |
| | Tablet containing medroxyprogesterone acetate 100 mg | Oral |
| | Tablet containing medroxyprogesterone acetate 200 mg | Oral |
| | Tablet containing medroxyprogesterone acetate 250 mg | Oral |
| | Tablet containing medroxyprogesterone acetate 5 mg | Oral |
| | Tablet containing medroxyprogesterone acetate 500 mg | Oral |
| Mefenamic acid | Capsule 250 mg | Oral |
| Meloxicam | Capsule 15 mg | Oral |
| | Capsule 7.5 mg | Oral |
| | Tablet 15 mg | Oral |
| | Tablet 7.5 mg | Oral |
| Melphalan | Tablet 2 mg | Oral |
| Memantine | Tablet containing memantine hydrochloride 10 mg | Oral |
| | Tablet containing memantine hydrochloride 20 mg | Oral |
| Mercaptopurine | Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL | Oral |
| | Tablet containing mercaptopurine monohydrate 50 mg | Oral |
| Mesalazine | Enemas 1 g in 100 mL, 7 | Rectal |
| | Enemas 2 g in 60 mL, 7 | Rectal |
| | Enemas 4 g in 60 mL, 7 | Rectal |
| | Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g | Rectal |
| | Sachet containing granules, 1 g per sachet | Oral |
| | Sachet containing granules, 1.5 g per sachet | Oral |
| | Sachet containing granules, 3 g per sachet | Oral |
| | Sachet containing granules, 500 mg per sachet | Oral |
| | Sachet containing prolonged release granules, 1 g per sachet | Oral |
| | Sachet containing prolonged release granules, 2 g per sachet | Oral |
| | Sachet containing prolonged release granules, 4 g per sachet | Oral |
| | Suppository (moulded) 1 g | Rectal |
| | Suppository 1 g | Rectal |
| | Tablet 1 g (enteric coated) | Oral |
| | Tablet 1 g (prolonged release) | Oral |
| | Tablet 1.2 g (prolonged release) | Oral |
| | Tablet 250 mg (enteric coated) | Oral |
| | Tablet 500 mg (enteric coated) | Oral |
| | Tablet 500 mg (prolonged release) | Oral |
| | Tablet 800 mg (enteric coated) | Oral |
| Mesna | Solution for I.V. injection 1 g in 10 mL ampoule | Injection |
| | Solution for I.V. injection 400 mg in 4 mL ampoule | Injection |
| Metformin | Tablet containing metformin hydrochloride 500 mg | Oral |
| | Tablet containing metformin hydrochloride 850 mg | Oral |
| | Tablet containing metformin hydrochloride 1 g | Oral |
| | Tablet (extended release) containing metformin hydrochloride 500 mg | Oral |
| | Tablet (extended release) containing metformin hydrochloride 1 g | Oral |
| | Tablet (prolonged release) containing metformin hydrochloride 500 mg | Oral |
| Metformin with glibenclam |